EFFECT OF ORAL ZINC SULFATE ON REDUCING HYPERBILIRUBINEMIA AMONG NEWBORNS UNDER 1800 GRAM

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

MAFINEZHAD SH.; BAYANI GH.; BOZORGNIA Y.; KHODAPARAST M.; JODAT SH.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Journal of North Khorasan University of Medical Sciences Year:2015 | Volume:7 | Issue:4 Page(s): 897-904

Download Full-Text

Persian Verion

View:

764

Download:

Cites:

Information Journal Paper

Title

EFFECT OF ORAL ZINC SULFATE ON REDUCING HYPERBILIRUBINEMIA AMONG NEWBORNS UNDER 1800 GRAM

Author(s)

Keywords

NEWBORNQ2

BILIRUBINQ2

ZINC SULFATEQ2

PHOTOTHERAPYQ2

Abstract

Background & Objectives: Jaundice is considered as a common clinical condition during. Prevention of severe hyperbilirubinemia is safer and easier than current therapies, like PHOTOTHERAPY or blood exchange. In some animal and human studies, zinc was found effective in reducing jaundice. In this study we evaluated the effect of oral ZINC SULFATE on serum BILIRUBIN of NEWBORNs under 1800 gram.Materials and Methods: This randomized, clinical trial was performed on preterm (<1800 gram) NEWBORNs borne within Bentolhoda hospital. Eligible preterm (<1800 gram) NEWBORNs aged 24±6 hours, were randomly allocated into two groups: group A (receiving ZINC SULFATE) and group B (placebo). They were screened by testing serum BILIRUBIN at the end of the third and seventh day of age. Laboratory results and duration of PHOTOTHERAPY were comparison between two groups.Results: Among 66 eligible NEWBORNs 32 were placed in group A and 34 in group B. The mean serum BILIRUBIN in group A and B was defined as 7.7±2 and 8.7±2, in the third day (P=0.053) and 6±2 vs 7.6±2 (P=0.012) in the seventh day, respectively and showed significant difference between two groups. Duration of PHOTOTHERAPY was recorded longer among placebo group (108 vs 84 hours).Conclusion: The current study showed that prophylactic administration of 10 mg ZINC SULFATE in preterm babies may reduce serum BILIRUBIN. Weight loss at the end of first week of life was less among NEWBORNs received ZINC SULFATE. Less PHOTOTHERAPY duration was reported in the zinc group in comparison with the placebo group. No acute adverse effects were reported in the zinc group.

Cites

No record.

References

No record.

Cite

APA: Copy

MAFINEZHAD, SH., BAYANI, GH., BOZORGNIA, Y., KHODAPARAST, M., & JODAT, SH.. (2015). EFFECT OF ORAL ZINC SULFATE ON REDUCING HYPERBILIRUBINEMIA AMONG NEWBORNS UNDER 1800 GRAM. JOURNAL OF NORTH KHORASAN UNIVERSITY OF MEDICAL SCIENCES, 7(4), 897-904. SID. https://sid.ir/paper/186995/en

Vancouver: Copy

MAFINEZHAD SH., BAYANI GH., BOZORGNIA Y., KHODAPARAST M., JODAT SH.. EFFECT OF ORAL ZINC SULFATE ON REDUCING HYPERBILIRUBINEMIA AMONG NEWBORNS UNDER 1800 GRAM. JOURNAL OF NORTH KHORASAN UNIVERSITY OF MEDICAL SCIENCES[Internet]. 2015;7(4):897-904. Available from: https://sid.ir/paper/186995/en

IEEE: Copy

SH. MAFINEZHAD, GH. BAYANI, Y. BOZORGNIA, M. KHODAPARAST, and SH. JODAT, “EFFECT OF ORAL ZINC SULFATE ON REDUCING HYPERBILIRUBINEMIA AMONG NEWBORNS UNDER 1800 GRAM,” JOURNAL OF NORTH KHORASAN UNIVERSITY OF MEDICAL SCIENCES, vol. 7, no. 4, pp. 897–904, 2015, [Online]. Available: https://sid.ir/paper/186995/en

Related Journal Papers